Mergers & Acquisitions
Americhem Acquires Noble Biomaterials to Add Antimicrobial and Conductive Technologies
By News Desk ·
Key takeaways
- Americhem acquired Noble Biomaterials, adding antimicrobial and conductive technologies for soft surface applications.
- Noble Biomaterials' IONIC+, X-STATIC and CIRCUITEX platforms serve apparel and textiles, healthcare, and aerospace and defense markets.
- Americhem CEO John Richard said the deal invests in high-growth, high-demand markets including healthcare and aerospace and defense.
Americhem has acquired Noble Biomaterials, adding antimicrobial and conductive technologies for soft surface applications to its polymer solutions platform. B2B Marketplace announced the deal without disclosing the price. Americhem is a global designer and manufacturer of custom polymer solutions. Noble Biomaterials is an advanced materials company specializing in antimicrobial and conductivity solutions for soft surface applications.
Americhem's Acquisition of Noble Biomaterials
Noble Biomaterials provides proprietary materials technology for mission-critical applications across apparel and textiles, healthcare, and aerospace and defense. Its flagship platforms, IONIC+, X-STATIC and CIRCUITEX, deliver advanced functional capabilities backed by U.S. manufacturing and an intellectual property portfolio built over two decades. Americhem said the acquisition adds Noble Biomaterials' differentiated technologies and deep specialization to its broader global platform, strengthening its ability to support customers from concept through scalable commercial production.
"This is an exciting step forward for Americhem as we continue to invest in high-growth, high-demand markets," said John Richard, Chief Executive Officer of Americhem. "Noble Biomaterials brings exceptional capabilities in antimicrobial solutions, strong commercial relationships and a reputation for quality that aligns with our values." Joel Furey, Founder and Chief Commercial Officer of Noble Biomaterials, said Americhem brings complementary capabilities, global reach, scalable resources and a customer-first culture. Kaitlyn Desai, Principal at PPC, said the technology and market focus align well with Americhem's strategic direction.
Americhem's Manufacturing and Product Record
According to akta.pro company records, Americhem operates 10 manufacturing plants globally to serve customers worldwide. The same records list a 2025 partnership with Cocona Labs for smart textiles development. Americhem launched its nDryve PFAS-free surface-modifying in-melt technology platform for functional fibers in April 2026, and its Laser Marking Solutions platform in June 2026.
Americhem's Earlier Expansion Moves
Americhem opened a new clean compounding facility in Suzhou, China, on September 28, according to FinancialContent Business Page. The facility meets ISO 13485 and cGMP requirements for medical device applications and expands Americhem's global clean compounding network. In October 2026, FinancialContent Business Page reported that Americhem announced the acquisition of Noble Biomaterials, an advanced materials company specializing in antimicrobial and conductivity solutions for soft surface applications.